| 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅%。 | | --- | --- | --- | --- | --- | --- | | 920576 | 天力复合 | 1 | 21.21 | 36.99亿 | 64.48 | | 301232 | 飞沃科技 | 1 | 20.00 | 70.17亿 | 277.98 | | 300620 | 光库科技 | 1 | 13.70 | 413 Z | 241.74 | | 300900 | 广联航空 | 1 | 13.53 | 72.06亿 | 10.23 | | 002512 | 达华智能 | 1 | 10.03 | 79.32亿 | 50.42 | | 000547 | 航天发展 | 4 | 10.01 | 362亿 | 209.58 | | 002792 | 通宇通讯 | 1 | 10.01 | 170亿 | 118.17 | | 003029 | 吉大正元 | 1 | 10.01 | 51.50亿 | 21.91 | | 002977 | 天箭科技 | 1 | 10.01 | 53.35亿 | 63.96 | | 688283 | 坤恒 ...

新京报贝壳财经讯 12月7日，广联航空（300900）发布公告称，公司收到灌南县监察委员会出具的《解 除留置通知书》，灌南县监察委员会已解除对公司控股股东、实际控制人、董事长王增夺的留置措施。 目前，王增夺已能正常履行公司法定代表人、董事长及董事会相关委员会成员等职责，公司生产经营情 况正常。董事、总经理杨怀忠不再代为履行公司法定代表人、董事长及董事会相关委员会成员等职责。 ...

数据宝统计，截至11:02，广联航空成交额11.89亿元，创2025年6月3日以来新高。最新股价上涨 14.93%，换手率22.52%。上一交易日该股全天成交额为11.22亿元。（数据宝） （文章来源：证券时报网） ...

Industry Overview - The commercial aerospace sector has seen renewed activity, with companies like Feiwo Technology rising over 18% and others such as Guanglian Aviation and Changguang Huaxin increasing by more than 10% [1] - The establishment of the Commercial Aerospace Department by the National Space Administration marks the first dedicated regulatory body for China's commercial aerospace industry [1] Regulatory Developments - The National Space Administration has issued the "Action Plan for Promoting High-Quality and Safe Development of Commercial Aerospace (2025-2027)," aiming for a significantly expanded industry scale and enhanced innovation by 2027 [1] - The core mission of the new department is to ensure safety while unlocking the vast potential of the commercial aerospace sector [1] Market Potential - The number of commercial aerospace companies in China has exceeded 600, indicating a rapidly growing industry [1] - The commercial aerospace sector is expected to become a key development direction in the national "14th Five-Year Plan," with systemic development opportunities arising from improved regulatory frameworks and supportive policies [1]

Group 1 - Century Huatong plans to change the use of 1.28 million repurchased shares from equity incentive plans to cancellation, reducing total share capital from 7.428 billion to 7.427 billion shares [2] - Wuliangye adjusts its 2025 investment plan, increasing the number of projects from 19 to 22 and changing the investment amount from 2.586 billion to 2.207 billion yuan [3] - Qingyue Technology is under investigation for suspected financial data fraud, with the possibility of forced delisting if found guilty [4] Group 2 - Kang Enbei's chairman and legal representative resigns due to work adjustments, along with another board member [5] - Tianshan Co. expects a tax payment of approximately 61.86 million yuan to impact its 2025 net profit [6] - Muyuan Foods reports a 20.43% year-on-year decline in November sales revenue from live pigs, totaling 9.39 billion yuan [7] Group 3 - GAC Group's November automobile sales decreased by 9.72% year-on-year, with total sales of 1.797 million vehicles [8] - Western Pastoral's fresh milk production in November increased by 6.3% month-on-month but decreased by 6.47% year-on-year [9] - Gemdale Group's November contracted area fell by 58.50% year-on-year, with a total contracted amount of 1.52 billion yuan [10] Group 4 - Zhenghong Technology reports November sales revenue of 4.5196 million yuan from live pigs, with a year-on-year decline of 21.83% [11] - Wens Foodstuff's November chicken sales reached 118 million birds, generating 3.324 billion yuan in revenue [12] - Meilixin's controlling shareholder plans to increase holdings by no less than 50 million yuan [13] Group 5 - Hongcheng Environment's subsidiary wins an 853 million yuan sewage treatment project [14] - Dongzhu Ecology wins a 397 million yuan environmental project [15] - Xindian Software secures a 54 million yuan project for digital community construction [16] Group 6 - China Chemical announces that its nylon new material project has reached full production [17] - Jiaojian Co. is in discussions regarding overdue payments related to financial products, clarifying that it bears no responsibility for these products [18] - Micron Biotech's product is included in the 2025 National Medical Insurance Directory [19] Group 7 - Yitian Intelligent plans to sell 600 smart computing machines for a total of 1.56 billion yuan [20] - First Venture's subsidiary receives an administrative penalty notice from Jiangsu Securities Regulatory Bureau [21] - China Insurance's vice president is under investigation for serious violations [22] Group 8 - Zhixiang Jintai's monoclonal antibody injection is included in the 2025 National Medical Insurance Directory [23] - Haichuang Pharmaceutical's drug is also included in the National Medical Insurance Directory [24] - Yuanli Co. plans to acquire 49% of Clarimex for 25.56 million USD [25] Group 9 - Betta Pharmaceuticals' products are included in the National Medical Insurance Directory [26] - Tianci Materials' controlling shareholder commits to not reducing holdings for six months [27] - Guanglian Aviation's actual controller has had a detention measure lifted [28] Group 10 - Annie Co. announces a share transfer agreement that will make Shengshi Tianan the controlling shareholder [29] - Double Star New Materials notes uncertainty regarding the sustainability of long-term price increases [30] - ST Tianrui terminates plans for a change in control and resumes trading [31] Group 11 - Guao Technology is planning a change in control, leading to a temporary suspension of its stock [32] - Guangqi Technology's subsidiary signs contracts worth 696 million yuan for the production of metamaterials [33] - Shuoshi Biotech's monkeypox virus detection kit is included in the WHO emergency use list [34]

Core Viewpoint - The General Aviation ETF (159378) has shown a significant increase, reflecting a strong growth trend in the low-altitude economy and drone manufacturing sector in China [1][3]. Group 1: Market Performance - As of December 8, 2025, the General Aviation ETF (159378) rose by 2.22%, marking its third consecutive increase [1]. - Key component stocks such as Tianyin Electromechanical (300342) increased by 11.99%, Aerospace Electronics (600879) by 10.01%, and China Satellite (600118) by 8.49% [1][2]. Group 2: Industry Growth - The low-altitude economy market in China is projected to reach 1.5 trillion yuan by 2025 and is expected to exceed 2 trillion yuan by 2030 [2]. - China holds a 70% share of the global consumer drone market, with 969 companies registered in the civil unmanned aerial vehicle product information system [2][3]. - The first four-seat electric aircraft has received a type certificate from the Civil Aviation Administration of China [2]. Group 3: Policy and Infrastructure - The Central Committee of the Communist Party of China has emphasized accelerating the development of strategic emerging industries, including the low-altitude economy [3]. - Local governments have been expediting the planning of low-altitude flight routes and airspace division since the second half of 2025, with ongoing policy support [3]. - Drones are rapidly expanding in both military and civilian sectors, particularly in logistics and emergency rescue applications [3]. Group 4: Investment Opportunities - The General Aviation ETF (159378) focuses on the low-altitude economy and drone sector, benefiting from the rapid development of integrated air, space, and ground capabilities [3]. - The ETF is the first and largest of its kind in the market, tracking the National Index of General Aviation Industry [3].

Group 1 - The commercial aerospace sector opened high on December 8, with Longzhou Co. achieving a four-day consecutive rise [2] - Shunhao Co. and Western Materials both recorded a two-day consecutive rise, while Zengsheng Technology hit the daily limit [2] - Hongxiang Co. increased by over 10%, with Aerospace Science and Technology, Guanglian Aviation, Tianjian Technology, Tefa Information, and Xunwei Communication also experiencing gains [2]

商业航天板块高开，龙洲股份4连板，顺灏股份、西部材料2连板，再升科技涨停，红相股份涨超10%， 航天科技、广联航空、天箭科技、特发信息、信维通信跟涨。 ...

Core Viewpoint - Guanglian Aviation's controlling shareholder and chairman Wang Zengduo has been released from detention, allowing him to resume his duties as the company's legal representative and chairman, with normal business operations continuing [1][5]. Company Overview - Guanglian Aviation focuses on the research, development, production, and manufacturing of high-end aerospace equipment and is a well-known private supplier of aerospace industrial support products in China [2][6]. - The company has advanced technology in composite material processing equipment, components, and segment manufacturing, and has participated in several large aircraft development projects approved by the state, including being a supplier for the C919 large passenger aircraft and the C929 cargo door components [2][6]. Leadership Background - Wang Zengduo, aged 63, graduated from Beihang University with a degree in Computer Science and Engineering and has held various leadership positions in the aerospace and manufacturing sectors since 1987 [4][8]. - His career includes roles such as technician at Harbin Aircraft Manufacturing Company, general manager at Harbin Plastic Industry Company, and chairman at multiple companies, culminating in his current position at Guanglian Aviation since March 2016 [4][8].

Group 1 - Heng Rui Pharmaceutical has 9 drugs included in the national medical insurance directory for the first time, with an estimated total sales of approximately 8.66 billion yuan for 2024 and 7.55 billion yuan for the first three quarters of 2025 [5] - Junshi Biosciences' products Tuoyi® and Junshida® have been added to the national medical insurance directory, enhancing patient affordability and market promotion [6] - Huadong Medicine's subsidiary has products included in the national medical insurance and commercial insurance innovative drug directories, expected to aid in market promotion [7] Group 2 - Aidi Pharmaceutical's two innovative HIV drugs have successfully renewed their inclusion in the national medical insurance directory, with specific reimbursement prices set [8] - Fuxing Pharmaceutical has multiple products newly included in the national medical insurance directory, which is anticipated to positively impact future performance [9] - Weichuang Biotechnology's product has been included in the national medical insurance directory, which is expected to enhance market promotion and sales [10] Group 3 - Muxi Co., Ltd. announced a final online issuance rate of 0.03348913% after the mechanism was activated, with a total of 22.83 million shares issued [2] - Doushan New Materials reached a consensus on production reduction in the BOPET industry, although the sustainability of long-term price increases remains uncertain [2] - Guanglian Aviation's controlling shareholder has had the detention lifted, allowing normal operations to resume [3] Group 4 - Jiangjian Co., Ltd. clarified that it bears no obligations for any overdue financial products related to its controlling shareholder, confirming normal operations [4] - Tian Ci Materials' controlling shareholder has committed not to reduce holdings, holding 34.35% of the shares [13] - Annie Co., Ltd. is planning a change in control, with stock resuming trading on December 8 [14]